Immuno-Oncology, Immune Therapy, PD-1 in Melanoma - Omid Hamid MD

Omid Hamid, MD, Chief of Experimental Therapeutics/Immuno-Oncology and Director of the Melanoma Program at The Angeles Clinic and Research Institute reviews the breakthroughs made thorough Immune therapy with PD-1 antibodies in Melanoma and new Predictive markers that can improve therapy at The Angeles Clinic Melanoma Education Symposium 2015 - www.theangelesclinic.org